ArticleCentral nervous system agents in medicinal chemistry2025
Analysis of Vit B6 in Raw Banana Peel, Phytochemical Screening, and Neuroprotective Effects.
Article in Central nervous system agents in medicinal chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEpilepsy contributes significantly to the burden of mental illness, with an estimated 50 million cases globally. Neuroprotection with herbal bioactives is a promising therapeutic strategy for the prevention and treatment of temporal lobe epilepsy. Banana peel is rich in antioxidants and anti-inflammatory compounds. It has the potency to protect against neuronal apoptosis primarily due to the presence of Vit B6 and flavones.
objectivesThis: study investigated the neuroprotective effects of Hydro-Alcoholic Extracts (HAE) of banana peel, prepared at solvent ratios of 90:10, 80:20, and 70:30, focusing on their anti- apoptotic, antioxidant, and anti-inflammatory activities.
methodsNeurons or neuronal cell lines were treated with HAE at 10-200 μg/mL concentrations. Apoptotic markers (cleaved caspase-3 and Bcl-2) were evaluated using ELISA, and the cleaved caspase-3/Bcl-2 ratio was calculated. Antioxidant effects were assessed via Glutamate Decarboxylase (GAD) and catalase activity assays, while pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) were quantified. Cell viability was analyzed using the MTT assay, and IC50 values were determined for apoptosis inhibition.
resultsHAE (90:10) at 100 μg/mL significantly reduced the cleaved caspase-3/Bcl-2 ratio (0.45±0.02), with an IC50 of 37.5±2.1 μg/mL, demonstrating superior anti-apoptotic activity. HAE (80:20) and HAE (70:30) exhibited IC50 values of 48.2±2.5 μg/mL and 62.7±3.0 μg/mL, respectively, indicating comparatively lower potency. Enhanced GAD (121.4±5.2 U/mg) and catalase (89.7±3.4 U/mg) activities with HAE (90:10) highlight its potent antioxidant effects. Significant reductions in pro-inflammatory markers, including TNF-α (decreased by 45.6±2.3% at 100 μg/mL), further underscore its anti-inflammatory potential. The MTT assay revealed improved cell viability, with HAE (90:10) maintaining 93.5±2.6% viability at 100 μg/mL. The superior performance of HAE (90:10) can be attributed to its optimized balance of bioactive compounds, supporting its neuroprotective properties.
conclusionHAE (90:10) emerged as the most promising candidate for neuroprotection, demonstrating potent anti-apoptotic, antioxidant, and anti-inflammatory effects. These findings suggest its potential application in managing neurodegenerative disorders, warranting further in vivo and clinical studies.
Indexed as
Identifiers
40211990What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.